These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35196337)

  • 1. Value of D-dimer in predicting various clinical outcomes following community-acquired pneumonia: A network meta-analysis.
    Li J; Zhou K; Duan H; Yue P; Zheng X; Liu L; Liao H; Wu J; Li J; Hua Y; Li Y
    PLoS One; 2022; 17(2):e0263215. PubMed ID: 35196337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
    Zhuang Q; Zeng Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
    Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study.
    Zhang Y; Zhou Q; Zou Y; Song X; Xie S; Tan M; Zhang G; Wang C
    J Thromb Thrombolysis; 2016 May; 41(4):619-27. PubMed ID: 26370200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia.
    Querol-Ribelles JM; Tenias JM; Grau E; Querol-Borras JM; Climent JL; Gomez E; Martinez I
    Chest; 2004 Oct; 126(4):1087-92. PubMed ID: 15486368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.
    Cerda-Mancillas MC; Santiago-Germán D; Andrade-Bravo B; Pedraza-Olivares F; Valenzo-Hernández F; Leaños-Miranda A; Isordia-Salas I
    Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Scally C; Hill AT
    Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission.
    Salluh JIF; Rabello LSCF; Rosolem MM; Soares M; Bozza FA; Verdeal JCR; Mello GW; Castro Faria Neto HC; Lapa E Silva JR; Bozza PT
    J Crit Care; 2011 Oct; 26(5):496-501. PubMed ID: 21454038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.
    Snijders D; Schoorl M; Schoorl M; Bartels PC; van der Werf TS; Boersma WG
    Eur J Intern Med; 2012 Jul; 23(5):436-41. PubMed ID: 22726372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia.
    Nastasijević Borovac D; Radjenović Petković T; Pejčić T; Stanković I; Janković I; Ćirić Z; Rančić M
    Med Glas (Zenica); 2014 Feb; 11(1):37-43. PubMed ID: 24496339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Fibrinogen Degradation Products and D-Dimer in the Differential Diagnosis of Pulmonary Tuberculosis and Community-Acquired Pneumonia.
    Min W; Zi-Feng J; Jian-Lin X; Hao-Hui F
    Clin Lab; 2018 Jan; 64(1):135-140. PubMed ID: 29479876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
    Liu S; He LR; Wang W; Wang GH; He ZY
    Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma d-dimer for outcome assessment in patients with CAP: not a replacement for PSI.
    McIvor RA
    Chest; 2004 Oct; 126(4):1015-6. PubMed ID: 15486354
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.
    Liu D; Xie L; Zhao H; Liu X; Cao J
    BMC Infect Dis; 2016 May; 16():232. PubMed ID: 27230573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between plasma D-dimer levels and community-acquired pneumonia.
    Arslan S; Ugurlu S; Bulut G; Akkurt I
    Clinics (Sao Paulo); 2010 Jun; 65(6):593-7. PubMed ID: 20613935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia.
    Shilon Y; Shitrit AB; Rudensky B; Yinnon AM; Margalit M; Sulkes J; Shitrit D
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):745-8. PubMed ID: 14614354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia?
    Ateş H; Ateş İ; Bozkurt B; Çelik HT; Özol D; Yldrm Z
    Blood Coagul Fibrinolysis; 2016 Apr; 27(3):252-8. PubMed ID: 26258679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive roles of D-dimer for mortality of patients with community-acquired pneumonia: a systematic review and meta-analysis.
    Yang C; Zeng HH; Huang J; Zhang QY; Lin K
    J Bras Pneumol; 2021; 47(6):e20210072. PubMed ID: 34932717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
    Dai RX; Kong QH; Mao B; Xu W; Tao RJ; Wang XR; Kong QY; Xu JF
    BMC Pulm Med; 2018 Jan; 18(1):12. PubMed ID: 29357862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Prealbumin Improves the Sensitivity of Pneumonia Severity Index in Predicting 30-day Mortality of CAP Patients.
    Zhang HF; Li LQ; Ge YL; Zhang JB; Fu AS; Liu CH; Shao DF; Bai J; Zhu XY
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.